A system for generating a concentrated product from a feedstock includes a feedstock chamber to which the feedstock is provided, a heat exchanger assembly in thermal communication with the feedstock chamber, the heat exchanger assembly being configured to freeze the feedstock in the feedstock chamber, an output flow arrangement configured to carry liquid from the feedstock chamber as the feedstock thaws, the output flow arrangement comprising a flow controller, a sensor disposed along the output flow arrangement or the heat exchanger assembly, the sensor being configured to measure a characteristic of the liquid, the characteristic being indicative of a solute concentration level of the liquid or the heat exchanger assembly, and a processor responsive to the characteristic and configured to control the flow controller to, based on the solute concentration level, direct the liquid passing through the output flow arrangement to define a plurality of products at different concentration levels, the plurality of products comprising the concentrated product.

A method for extracting an analyte from a solid sample is described. The sample is sealed in a porous membrane bag, which is sonicated in an organic solvent. An extract of the analyte forms in the bag and diffuses into the organic solvent. The organic solvent containing the extract may then be concentrated and analyzed for an analyte with gas chromatography-mass spectrometry. The method does not the use of a solid sorbent material, and does not require a step of centrifuging or filtering.

A process for decreasing contamination of a commercial refining process by vanadyl porphyrins and/or nickel porphyrins by allowing rapid screening of porphyrins directly from asphaltenes isolated from crude oil without enrichment by use of positive-ion electrospray ionization mass spectrometry (ESI MS). Sodium formate is utilized as a ESI spray modifier. The vanadyl porphyrins are detected predominantly as sodiated species, while nickel porphyrins are observed as both sodiated species and molecular ions. Crude oil feedstocks exceeding a defined threshold concentration of vanadyl porphyrins and/or nickel porphyrins are rejected or diluted prior to utilization as refinery feedstock. Certain embodiments additionally quantitate both deoxophylloerythroetioporphyrins and etioporphyrin content (and their ratio) to predict crude oil thermal maturity.

An analytical system and method for detecting volatile organic chemicals in water including a coated SAW detector that provides for improved reduction of moisture at the coating of the SAW detector. A stabilized SAW sensitivity and long lasting calibration is achieved. The analytical system further includes an improved sample vessel and sparger that allow for easy grab sample analysis, while also providing efficient purging of the volatile organic compounds from the water sample. In addition, an improved preconcentrator provides a stabilized sorbent bed.

A precipitate and/or an inclusion in a metal material is extracted by electrolysis using an electrolyte solution. The electrolyte solution contains an adsorbent that is adsorbed to a surface of the precipitate and/or a surface of the inclusion. The extracted precipitate and/or the inclusion can be quantitatively analyzed with high accuracy.

The present invention relates to a method of removing an RNA fraction with ≥200 nucleotides in length from a whole blood sample. The present invention also relates to a method of purifying an RNA fraction with <200 nucleotides in length from a whole blood sample. The present invention further relates to a method of determining the level of RNA molecules with <200 nucleotides in length. In addition, the present invention relates to a method for diagnosing a disease in an individual. Moreover, the present invention relates to a kit which is useful for carrying out the methods of the present invention.

A component extraction apparatus includes a rack placement part, a heater, an extraction medium supply part, a needle assembly, and a temperature sensor. When the container rack is mounted on the rack placement part, a heater is configured to heat the sample containers in direct or indirect contact with sample containers held by the container rack. The needle assembly holds a needle with a tip thereof pointing downward, and the needle being configured to connect a flow channel by inserting the tip thereof into a needle port provided on an upper surface of each of the sample containers. The temperature sensor is included in the needle assembly and is configured to detect a temperature of the upper surface of any one of the sample containers when the tip of the needle is inserted into the needle port of the one of the sample containers.

In a pretreatment method, in first step, a sample is dissolved in 1,1,1,3,3,3-hexafluoro-2-propanol to prepare a first solution. In second step, an organic base is added to the first solution to prepare a second solution. In third step, the second solution is heated to obtain a substance in which an anhydrous oxide structure in the sample has been decomposed. In a fourth step, an organic solvent that has a higher boiling point than that of 1,1,1,3,3,3-hexafluoro-2-propanol and is compatible (miscible) with 1,1,1,3,3,3-hexafluoro-2-propanol is added to the second solution to prepare a third solution.

An embodiment provides a method for deriving an amount of PFAS substances from a total organic fluoride measurement in a sample, including: removing inorganic fluoride from the sample using one or more of an ion exchange cartridge and an exclusion apparatus; preconcentrating, using a solid phase extraction, at least one PFAS substance in the sample; digesting, using a working electrode and a counter electrode, the at least one PFAS substance to an amount of total organic fluoride; and determining, using an analyzer, the amount of total organic fluoride in the sample. Other aspects are described and claimed.

The present disclosure provides methods to quantify tau phosphorylation at specific amino acid residues, using blood samples, to predict time to onset of mild cognitive impairment due to Alzheimer's disease, stage Alzheimer's disease, guide treatment decisions, select subjects for clinical trials, and evaluate the clinical efficacy of certain therapeutic interventions.